209 related articles for article (PubMed ID: 31368847)
1. Colorectal cancer: pharmacogenetics support for the correct drug prescription.
Olivera G; Sendra L; Herrero MJ; Puig C; Aliño SF
Pharmacogenomics; 2019 Jul; 20(10):741-763. PubMed ID: 31368847
[TBL] [Abstract][Full Text] [Related]
2. The role of pharmacogenetics in the new ESMO colorectal cancer guidelines.
Schirripa M; Procaccio L; Lonardi S; Loupakis F
Pharmacogenomics; 2017 Feb; 18(3):197-200. PubMed ID: 28112993
[No Abstract] [Full Text] [Related]
3. Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer.
Moradi-Marjaneh R; Khazaei M; Seifi S; Hassanian SM; Ferns GA; Avan A
Curr Pharm Des; 2018; 24(23):2710-2718. PubMed ID: 30051785
[TBL] [Abstract][Full Text] [Related]
4. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin E; De Mattia E; Ecca F; Toffoli G
Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of colorectal cancer.
Marsh S
Expert Opin Pharmacother; 2005 Dec; 6(15):2607-16. PubMed ID: 16316300
[TBL] [Abstract][Full Text] [Related]
6. Progress in pharmacogenetics: consortiums and new strategies.
Maroñas O; Latorre A; Dopazo J; Pirmohamed M; Rodríguez-Antona C; Siest G; Carracedo Á; LLerena A
Drug Metab Pers Ther; 2016 Mar; 31(1):17-23. PubMed ID: 26913460
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
8. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
Nagy M; Attya M; Patrinos GP
Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
[TBL] [Abstract][Full Text] [Related]
9. Precision Medicine in Oncology Pharmacy Practice.
Saadeh C; Bright D; Rustem D
Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.
Weng L; Zhang L; Peng Y; Huang RS
Pharmacogenomics; 2013 Feb; 14(3):315-24. PubMed ID: 23394393
[TBL] [Abstract][Full Text] [Related]
11. PharmGKB: A worldwide resource for pharmacogenomic information.
Barbarino JM; Whirl-Carrillo M; Altman RB; Klein TE
Wiley Interdiscip Rev Syst Biol Med; 2018 Jul; 10(4):e1417. PubMed ID: 29474005
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics implementation in the clinics: information and guidelines for germline variants.
Olivera G; Sendra L; Herrero MJ; Berlanga P; Gargallo P; Yáñez Y; Urtasun A; de Mora JF; Castel V; Cañete A; Aliño SF
Cancer Drug Resist; 2019; 2(1):53-68. PubMed ID: 35582138
[TBL] [Abstract][Full Text] [Related]
14. [Role of pharmacogenetics in chemotherapy of colorectal cancers].
Ceppa F; Fontan E; Cremades S; Bihannic R; Bousquet A; Beauvillain L; Burnat P
Rev Med Interne; 2007 Sep; 28(9):594-602. PubMed ID: 17624636
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics Clinical Annotation Tool (PharmCAT).
Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE
Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.
Panczyk M
World J Gastroenterol; 2014 Aug; 20(29):9775-827. PubMed ID: 25110414
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics of colorectal cancer prevention and treatment.
Nguyen H; Tran A; Lipkin S; Fruehauf JP
Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
[TBL] [Abstract][Full Text] [Related]
18. PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19.
Huddart R; Whirl-Carrillo M; Altman RB; Klein TE
Clin Pharmacol Ther; 2021 Jan; 109(1):116-122. PubMed ID: 32978778
[TBL] [Abstract][Full Text] [Related]
19. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
Johnson JA; Burkley BM; Langaee TY; Clare-Salzler MJ; Klein TE; Altman RB
Clin Pharmacol Ther; 2012 Oct; 92(4):437-9. PubMed ID: 22910441
[TBL] [Abstract][Full Text] [Related]
20. What is the role and impact of molecular markers on treatment decisions for colorectal cancer in the adjuvant setting?
Al-Salama HM; Johnstone EC; Kerr DJ
Discov Med; 2009 Oct; 8(42):104-7. PubMed ID: 19833054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]